SCHEMBL1939742

SCHEMBL1939742

C1=NCC(c2ccncc2)CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 3/20 0.37
CYP1A2 P05177 2/20 0.37
CYP19A1 P11511 5/20 0.34
TP53 P04637 2/20 0.33
S1PR1 P21453 1/20 0.33
DDB1 Q16531 1/20 0.33
CRBN Q96SW2 1/20 0.33
CYP11B2 P19099 2/20 0.32
HSD11B1 P28845 1/20 0.32
OPRM1 P35372 1/20 0.32
OPRL1 P41146 1/20 0.32
MAPT P10636 2/20 0.31
CYP2D6 P10635 2/20 0.31
MEN1 O00255 1/20 0.31
ALDH1A1 P00352 1/20 0.31
LMNA P02545 1/20 0.31
CHRM1 P11229 1/20 0.31
TSHR P16473 1/20 0.31
MAPK1 P28482 1/20 0.31
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10642762 0.82 SLC18A3 (0.42) CYP2C19CYP1A2MAPTCYP2D6TSHR
SCHEMBL4075039 0.74 TP53 (0.40) CYP2C19CYP1A2CYP19A1TP53S1PR1
SCHEMBL1515154 0.73 CYP11B2 (0.48) CYP2C19CYP1A2CYP19A1TP53S1PR1
SCHEMBL6419399 0.73 CYP11B2 (0.54) CYP2C19CYP1A2CYP19A1TP53S1PR1
SCHEMBL1515255 0.73
SCHEMBL21078346 0.72 CYP11B2 (0.40) CYP2C19CYP1A2CYP19A1TP53S1PR1
SCHEMBL24556967 0.72 CYP11B2 (0.57) CYP2C19CYP1A2TP53S1PR1CYP11B2
SCHEMBL60634 0.72 CYP11B2 (0.57) CYP2C19CYP1A2TP53S1PR1CYP11B2
SCHEMBL24556963 0.72 CYP11B2 (0.57) CYP2C19CYP1A2TP53S1PR1CYP11B2
SCHEMBL24602720 0.72 CYP11B2 (0.57) CYP2C19CYP1A2TP53S1PR1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2331522-A2 TETRAHYDROPYRIDINYL AND DIHYDROPYRROLYL COMPOUNDS AND THE USE THEREOF Purdue Pharma LP (US) 2011-06-15 EP disclosed
EP-2235010-A1 BICYCLIC DERIVATIVES FOR USE IN THE TREATMENT OF ANDROGEN RECEPTOR ASSOCIATED CONDITIONS AstraZeneca AB (SE) 2010-10-06 EP disclosed
WO-2009081197-A1 BICYCLIC DERIVATIVES FOR USE IN THE TREATMENT OF ANDROGEN RECEPTOR ASSOCIATED CONDITIONS ASTRAZENECA AB (SE) 2009-07-02 WO disclosed